EGI
IMMU

EAM Global Investors’s Immunomedics Inc IMMU Stock Holding History

EAM Global Investors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-37,667
Closed -$892K – 205
2018
Q2 		$892K Sell
37,667
-19,620
-34% -$394K 0.44% 135
2018
Q1 		$837K Sell
57,287
-12,683
-18% -$207K 0.43% 122
2017
Q4 		$1.13M Buy
+69,970
New +$826K 0.58% 63

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM Global Investors's IMMU Position: Q3 2018 in Review

EAM Global Investors sold out of Immunomedics Inc (IMMU) in Q3 2018, closing a stake of 37,667 shares — an estimated $892K sold.

EAM Global Investors first reported a position in IMMU in Q4 2017 and held it in 3 quarters. The position peaked at $1.13M in Q4 2017. 207 funds tracked by Wall St. Rank hold IMMU as of Q3 2018.

  • EAM Global Investors reported no remaining Immunomedics Inc position as of Q3 2018 after selling out during the quarter.
  • EAM Global Investors sold 37,667 Immunomedics Inc shares in Q3 2018, an estimated $892K.
  • EAM Global Investors first reported a position in Immunomedics Inc in Q4 2017 and held it in 3 quarters.
  • EAM Global Investors's Immunomedics Inc position peaked at $1.13M in Q4 2017.
  • 207 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2018.

Based on EAM Global Investors's 13F filing for Q3 2018, filed 8 Nov 2018.